Prognoses did not significantly differ between patients with high and low SCARA5 expression (Figure 4(c) and Table 5), while the K-M univariate analysis indicated that sex, T/N classification, tumor volume, clinical stage, and longest diameter of tumor were associated with prognosis (Figures 4(d)–4(i) and Table 5); Cox multivariate analysis indicated that tumor volume and T classification were both independent prognostic factors (Table 5). The gene discussed is SCARA5; the disease is neoplasm.